Publications by authors named "Ruigang Diao"

Article Synopsis
  • Recent trials indicate that combining PD-1 inhibitors with chemotherapy leads to better survival outcomes in patients with advanced esophageal squamous cell carcinoma (ESCC) compared to chemotherapy alone, though no definitive comparisons exist.
  • This study analyzed data from 4,162 patients across seven trials and found that PD-1 inhibitors increased median overall survival (OS) from 11.3 months to 15.6 months, with certain combinations offering the best results.
  • Key findings showed that the combinations of toripalimab, tislelizumab, and sintilimab yielded the longest OS, with sintilimab also demonstrating superior effectiveness over pembrolizumab for patients with higher combined positive scores.
View Article and Find Full Text PDF

Background: The sharp increase in fungal infections, insufficient diagnostic and treatment capabilities for fungal infections, poor prognosis of patients with fungal infections as well as the increasing drug resistance of fungi are serious clinical problems. It is necessary to explore the implementation and evaluation methods of antifungal stewardship (AFS) to promote the standardized use of antifungal drugs.

Methods: The AFS programme was implemented at a tertiary first-class hospital in China using a plan-do-check-act (PDCA) quality management tool.

View Article and Find Full Text PDF

Bladder cancer (BLCA) is one of the most malignant cancers worldwide, and its prognosis varies. 1214 BLCA samples in five different datasets and 2 platforms were enrolled in this study. By utilizing the gene expression in The Cancer Genome Atlas (TCGA) dataset, and another two datasets, in GSE13507 and GSE31684, we constructed a risk score staging system with Cox multivariate regression to evaluate predict the outcome of BLCA patients.

View Article and Find Full Text PDF

The prognosis of colorectal carcinoma (CRC) is unstable in the stage II-III patients. Patients with early stage II CRC have a relative poor prognosis while other stage III CRC patients have a better prognosis. In our work, by utilizing the expression of lncRNAs and mRNAs measured by microarray (GSE39582), we constructed a risk score staging system with Cox multivariate regression model to predict the outcome of grade II-III CRC patients.

View Article and Find Full Text PDF

Woad root has been used for the prevention of influenza for hundreds of years in many Asian countries. In this study, the antiviral modes of clemastanin B (CB), epigoitrin, phenylpropanoid portion (PEP), and the mixture of phenylpropanoids, alkaloids, and organic acid portions (PEP + ALK + OA) from wood root extract against influenza virus A FM1 were investigated. The results revealed that CB, epigoitrin, PEP, and PEP + ALK + OA exert their anti-influenza activity via inhibiting the virus multiplication, prophylaxis, and blocking the virus attachment.

View Article and Find Full Text PDF